DJIA 17,672.60 -141.38 -0.79%
NASDAQ 4,757.88 7.48 0.16%
S&P 500 2,051.82 -11.33 -0.55%
market minute promo

Pfizer (NYSE: PFE)

32.45 -0.36 (-1.10%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

PFE $32.45 -1.10%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $32.87
Previous Close $32.81
Daily Range $32.43 - $32.90
52-Week Range $27.51 - $33.50
Market Cap $204.5B
P/E Ratio 20.25
Dividend (Yield) $1.12 (3.4%)
Ex-Dividend Date
Dividend Pay Date
Volume 25,957,891
Average Daily Volume 26,111,931
Current FY EPS $2.26





Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website:

News & Commentary

These 3 Dividend Stocks Could Crush the Market in 2015

AbbVie, Amgen, and Pfizer are three dividend stocks that could crush the broader market this year. Here's why.

This Stock Could Become the Next Johnson & Johnson

Our Motley Fool contributors think that these three companies could one day be as revered as J&J.

Will Novartis' (NVS) Earnings Disappoint Expectations in Q4? - Analyst Blog

Will Oncology Products Drive Bristol-Myers (BMY) Earnings? - Analyst Blog

Pharmaceuticals Sector To See High Voltage Action in 2015

Pfizer Earnings Preview: Vaccines & Oncology Will Shine, But The Company Needs More

XLV, JNJ, PFE, MRK: Large Outflows Detected at ETF

Without Question, This Company Puts Its Shareholders First

Three Motley Fool analysts tell investors which companies they believe are the most shareholder friendly.

Gilead Sciences Still has More Upside

Immunomedics Reports Data on Oncology Candidate - Analyst Blog

Immunomedics Reports Data on Oncology Candidate - Analyst Blog

See More PFE News...

PFE's Top Competitors

PFE $32.45 (-1.10%)
Current stock: PFE
JNJ $102.20 (-1.50%)
Current stock: JNJ
ROG $76.10 (1.60%)
Current stock: ROG
GSK $45.01 (0.11%)
Current stock: GSK